The Cambridge Ion Channel Forum (CICF)
Event details
Metrion Biosciences and AstraZeneca are delighted to be co-hosting the Cambridge Ion Channel Forum, for the third time since the 2019 event.
A day of ion channel drug discovery focused presentations at the Discovery Centre, AstraZeneca, Cambridge. The event will commence in 8th May 2024, the event will start at 12pm BST with a networking lunch and concluding at 7pm following a drinks reception.
The speaker line up is as follows:
Dr Aneesh Karatt Vellatt, CSO – Maxion Therapeutics – Targeting ion channels with antibodies and antibody fusion molecules
Dr Trevor Wilkinson, Director in Biologics Engineering – AstraZeneca – Modulating Ion Channel Function with Biologics: Opportunities and Challenges
Ms Kathryn Smith, PhD Candidate – Tucker Lab, University of Oxford – Approaches to functional modulation of K2P K+ channels by nanobodies
Dr Yichen Qiu, Research fellow, Lignani Lab, Department of Clinical and Experimental Epilepsy – University College London – On-demand Kv1.1 gene therapy for brain circuit disorders
Mr Steve Trim, CSO – Venomtech – Ligands with bite! A potted history of how toxins became vital to ion channel research?
Dr Zeki Ilkan, Scientist – Metrion Biosciences – A Fluorescence-based drug repurposing screen of the potassium channel, KV3.1 with V434L mutation